Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives

Journal of Gene Medicine

Volumn 7, Issue 8, 2005, Pages 992-1009

  Neu, Michael ^a   Fischer, Dagmar ^a   Kissel, Thomas ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cationic polymer; Gene therapy; Non viral; Poly(ethyleneimine; Polyplex

Indexed keywords

COPOLYMER; DNA; MACROGOL; NUCLEIC ACID; POLYCATION; POLYETHYLENEIMINE; POLYMER; RNA;

BIODEGRADABILITY; CHEMICAL STRUCTURE; COMPLEX FORMATION; CYTOTOXICITY; DISULFIDE BOND; DRUG FORMULATION; DRUG STABILITY; GENE TARGETING; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR WEIGHT; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SAFETY; SYNTHESIS;

CROSS-LINKING REAGENTS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; MACROMOLECULAR SUBSTANCES; POLYETHYLENEIMINE;

EID: 23944464631     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.773     Document Type: Review

References (164)

1. Merdan T, Kopecek J, Kissel T. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv Drug Deliv Rev 2002; 54: 715-758.
2. Ziady AG, Davis PB, Konstan MW. Non-viral gene transfer therapy for cystic fibrosis. Expert Opin Biol Ther 2003; 3: 449-458.
3. Ferrari S, Geddes DM, Alton EW. Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. Adv Drug Deliv Rev 2002; 54: 1373-1393.
4. Griesenbach U, Ferrari S, Geddes DM, et al. Gene therapy progress and prospects: cystic fibrosis. Gene Ther 2002; 9: 1344-1350.
5. Onodera M, Sakiyama Y. Adenosine deaminase deficiency as the first target disorder in gene therapy. Expert Opin Investig Drugs 2000; 9: 543-549.
6. Buchschacher GL Jr, Wong-Staal F. Approaches to gene therapy for human immunodeficiency virus infection. Hum Gene Ther 2001; 12: 1013-1019.
7. Edelstein ML, Abedi MR, Wixon J, et al. Gene therapy clinical trials worldwide 1989-2004 - an overview. J Gene Med 2004; 6: 597-602.
8. Available: http://www.wiley.co.uk/genmed/clinical. Accessed January 2005.
9. Gore M. Gene therapy can cause leukaemia: no shock, mild horror but a probe. Gene Ther 2003; 10: 4.
10. Gansbacher B. Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT). J Gene Med 2003; 5: 261-262.
11. Duzgunes N, De Ilarduya CT, Simoes S, et al. Cationic liposomes for gene delivery: novel cationic lipids and enhancement by proteins and peptides. Curr Med Chem 2003; 10: 1213-1220.
12. Liu D, Ren T, Gao X. Cationic transfection lipids. Curr Med Chem 2003; 10: 1307-1315.
13. Gebhart CL, Kabanov AV. Evaluation of polyplexes as gene transfer agents. J Control Release 2001; 73: 401-416.
14. Boussif O, Lezoualc'h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 1995; 92: 7297-7301.
15. Abdallah B, Hassan A, Benoist C, et al. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther 1996; 7: 1947-1954.
16. Ferrari S, Moro E, Pettenazzo A, et al. ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Ther 1997; 4: 1100-1106.
17. Fischer D, Li Y, Ahlemeyer B, et al. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 2003; 24: 1121-1131.
18. Fischer D, Bieber T, Li Y, et al. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 1999; 16: 1273-1279.
19. Forrest ML, Koerber JT, Pack DW. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjugate Chem 2003; 14: 934-940.
20. Dick CR, Ham GE. Characterization of polyethyleneimine. J Macromol Sci 1970; A4: 1301-1314.
21. von Harpe A, Petersen H, Li Y, et al. Characterization of commercially available and synthesized polyethylenimines for gene delivery. J Control Release 2000; 69: 309-322.
22. Fischer D, von Harpe A, Kunath K, et al. Copolymers of ethyleneimine and N-(2-hydroxyethyl)ethyleneimine as tools to study effects of polymer structure on physicochemical and biological properties of DNA complexes. Bioconjugate Chem 2002; 13: 1124-1133.
23. Kramer M, Stumbe JF, Grimm G, et al. Dendritic polyamines: simple access to new materials with defined treelike structures for application in nonviral gene delivery. Chembiochem 2004; 5: 1081-1087.
24. Available: http://www.polymerenterprises.com. Accessed 2004.
25. Suh J, Paik HJ, Hwang BK. Ionization of poly(ethylenimine) and poly(allylamine) at various pHs. Bioorg Chem 1994; 22: 318-327.
26. Choosakoonkriang S, Lobo BA, Koe GS, et al. Biophysical characterization of PEI/DNA complexes. J Pharm Sci 2003; 92: 1710-1722.
27. Godbey WT, Barry MA, Saggau P, et al. Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J Biomed Mater Res 2000; 51: 321-328.
28. Funhoff AM, Van Nostrum CF, Koning GA, et al. Endosomal escape of polymeric gene delivery complexes is not always enhanced by polymers buffering at low pH. Biomacromolecules 2004; 5: 32-39.
29. Merdan T, Kunath K, Fischer D, et al. Intracellular processing of poly(ethyleneimine)/ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiments. Pharm Res 2002; 19: 140-146.
30. Sonawane ND, Szoka FC Jr, Verkman AS. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem 2003; 278: 44826-44831.
31. Thomas M, Klibanov AM. Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A 2002; 99: 14 640-14 645.
32. Mahato R, Furgeson D, Maheshwari A, et al. Polymeric gene delivery for cancer treatment. In Biomaterials and Drug Delivery Towards New Millenium, Park K, Kwon I, Yui N, Jeong S, Park K (eds). Han Rim Wonn Publishing: Seoul, Korea, 2000; 249-280.
33. Wolfert MA, Seymour LW. Atomic force microscopic analysis of the influence of the molecular weight of poly(L)lysine on the size of polyelectrolyte complexes formed with DNA. Gene Ther 1996; 3: 269-273.
34. Dunlap DD, Maggi A, Soria MR, et al. Nanoscopic structure of DNA condensed for gene delivery. Nucleic Acids Res 1997; 25: 3095-3101.
35. Bloomfield VA. DNA condensation. Curr Opin Struct Biol 1996; 6: 334-341.
36. Bronich T, Kabanov A, Marky L. A thermodynamic characterization of the interaction of a cationic copolymer with DNA. J Phys Chem B 2001; 105: 6041-6050.
37. Tang MX, Szoka FC. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther 1997; 4: 823-832.
38. Kabanov VA, Kabanov AV. Interpolyelectrolyte and block ionomer complexes for gene delivery: physico-chemical aspects. Adv Drug Deliv Rev 1998; 30: 49-60.
39. Cherng JY, Schuurmans-Nieuwenbroek NM, Jiskoot W, et al. Effect of DNA topology on the transfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid complexes. J Control Release 1999; 60: 343-353.
40. Ungaro F, De Rosa G, Miro A, et al. Spectrophotometric determination of polyethylenimine in the presence of an oligonucleotide for the characterization of controlled release formulations. J Pharm Biomed Anal 2003; 31: 143-149.
41. Clamme JP, Azoulay J, Mely Y. Monitoring of the formation and dissociation of polyethylenimine/DNA complexes by two photon fluorescence correlation spectroscopy. Biophys J 2003; 84: 1960-1968.
42. Boeckle S, Katharina von Gersdorff, Silke van der Piepen CC, et al. Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer. J Gene Med 2004; 6: 1102-1110.
43. Vinogradov SV, Bronich TK, Kabanov AV. Self-assembly of polyamine-poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides. Bioconjugate Chem 1998; 9: 805-812.
44. Behr JP, Demeneix B, Loeffler JP, et al. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc Natl Acad Sci U S A 1989; 86: 6982-6986.
45. Ruponen M, Ronkko S, Honkakoski P, et al. Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes. J Biol Chem 2001; 276: 33 875-33 880.
46. Kopatz I, Remy JS, Behr JP. A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin. J Gene Med 2004; 6: 769-776.
47. Erbacher P, Bettinger T, Belguise-Valladier P, et al. Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J Gene Med 1999; 1: 210-222.
48. Kunath K, von Harpe A, Petersen H, et al. The structure of PEG-modified poly(ethylene imines) influences biodistribution and pharmacokinetics of their complexes with NF-kappaB decoy in mice. Pharm Res 2002; 19: 810-817.
49. Merdan T, Callahan J, Petersen H, et al. Pegylated polyethylenimine-fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells. Bioconjugate Chem 2003; 14: 989-996.
50. Schaffer DV, Lauffenburger DA. Optimization of cell surface binding enhances efficiency and specificity of molecular conjugate gene delivery. J Biol Chem 1998; 273: 28 004-28 009.
51. Brus C, Petersen H, Aigner A, et al. Efficiency of polyethylenimines and polyethylenimine-graft-poly(ethylene glycol) block copolymers to protect oligonucleotides against enzymatic degradation. Eur J Pharm Biopharm 2004; 57: 427-430.
52. Oh YK, Suh D, Kim JM, et al. Polyethylenimine-mediated cellular uptake, nucleus trafficking and expression of cytokine plasmid DNA. Gene Ther 2002; 9: 1627-1632.
53. Marschall P, Malik N, Larin Z. Transfer of YACs up to 2.3 Mb intact into human cells with polyethylenimine. Gene Ther 1999; 6: 1634-1637.
54. Merdan T. Comparison of in vitro and in vivo properties of electrostatic complexes prepared with either polyethylenimine or pegylated polyethylenimine and plasmid DNA. Bioconjugate Chem. 2004; PhD Thesis, Philipps University of Marburg, Germany.
55. Moret I, Esteban Peris J, Guillem VM, et al. Stability of PEI-DNA and DOTAP-DNA complexes: effect of alkaline PH, heparin and serum. J Control Release 2001; 76: 169-181.
56. Kunath K, von Harpe A, Fischer D, et al. Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J Control Release 2003; 89: 113-125.
57. Petersen H, Kunath K, Martin AL, et al. Star-shaped poly(ethylene glycol)-block-polyethylenimine copolymers enhance DNA condensation of low molecular weight polyethylenimines. Biomacromolecules 2002; 3: 926-936.
58. Brissault B, Kichler A, Guis C, et al. Synthesis of linear polyethylenimine derivatives for DNA transfection. Bioconjug Chem 2003; 14: 581-587.
59. Gosselin MA, Guo W, Lee RJ. Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjugate Chem 2001; 12: 989-994.
60. Wolfert MA, Dash PR, Nazarova O, et al. Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA. Bioconjugate Chem 1999; 10: 993-1004.
61. Reschel T, Konak C, Oupicky D, et al. Physical properties and in vitro transfection efficiency of gene delivery vectors based on complexes of DNA with synthetic polycations. J Control Release 2002; 81: 201-217.
62. Banerjee P, Reichardt W, Weissleder R, et al. Novel hyperbranched dendron for gene transfer in vitro and in vivo. Bioconjugate Chem 2004; 15: 960-968.
63. Itaka K, Harada A, Yamasaki Y, et al. In situ single cell observation by fluorescence resonance energy transfer reveals fast intra-cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine. J Gene Med 2004; 6: 76-84.
64. Wang DA, Narang AS, Kotb M, et al. Novel branched poly(ethylenimine)-cholesterol water-soluble lipopolymers for gene delivery. Biomacromolecules 2002; 3: 1197-1207.
65. Godbey WT, Wu KK, Mikos AG. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res 1999; 45: 268-275.
66. Hunter AC, Moghimi SM. Therapeutic synthetic polymers: a game of Russian roulette? Drug Discov Today 2002; 7: 998-1001.
67. Petersen H, Fechner PM, Martin AL, et al. Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjugate Chem 2002; 13: 845-854.
68. Jeong JH, Song SH, Lim DW, et al. DNA transfection using linear poly(ethylenimine) prepared by controlled acid hydrolysis of poly(2-ethyl-2-oxazoline). J Control Release 2001; 73: 391-399.
69. Boussif O, Zanta MA, Behr JP. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther 1996; 3: 1074-1080.
70. Kircheis R, Wightman L, Wagner E. Design and gene delivery activity of modified polyethylenimines. Adv Drug Deliv Rev 2001; 53: 341-358.
71. Goula D, Remy JS, Erbacher P, et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther 1998; 5: 712-717.
72. Hartikka J, Bozoukova V, Jones D, et al. Sodium phosphate enhances plasmid DNA expression in vivo. Gene Ther 2000; 7: 1171-1182.
73. Kwok KY, Yang Y, Rice KG. Evolution of cross-linked non-viral gene delivery systems. Curr Opin Mol Ther 2001; 3: 142-146.
74. Dash PR, Read ML, Barrett LB, et al. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther 1999; 6: 643-650.
75. Ogris M, Steinlein P, Kursa M, et al. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther 1998; 5: 1425-1433.
76. Trubetskoy VS, Loomis A, Slattum PM, et al. Caged DNA does not aggregate in high ionic strength solutions. Bioconjugateem 1999; 10: 624-628.
77. Sung SJ, Min SH, Cho KY, et al. Effect of polyethylene glycol on gene delivery of polyethylenimine. Biol Pharm Bull 2003; 26: 492-500.
78. Wightman L, Kircheis R, Rossler V, et al. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene Med 2001; 3: 362-372.
79. Lemieux P, Vinogradov SV, Gebhart CL, et al. Block and graft copolymers and NanoGel copolymer networks for DNA delivery into cell. J Drug Target 2000; 8: 91-105.
80. Jevprasesphant R, Penny J, Jalal R, et al. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm 2003; 252: 263-266.
81. Toncheva V, Wolfert MA, Dash PR, et al. Novel vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymers. Biochim Biophys Acta 1998; 1380: 354-368.
82. Woodle MC. Controlling liposome blood clearance by surface-grafted polymers. Adv Drug Deliv Rev 1998; 32: 139-152.
83. O'Riordan CR, Lachapelle A, Delgado C, et al. PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum Gene Ther 1999; 10: 1349-1358.
84. Roberts MJ, Bentley MD, Harris JM. Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 2002; 54: 459-476.
85. Petersen H, Fechner PM, Fischer D, et al. Synthesis, characterization, and biocompatibility of polyethylenimine-graft-poly(ethylene glycol) block copolymers. Macromolecules 2002; 35: 6867-6874.
86. Sagara K, Kim SW. A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes. J Control Release 2002; 79: 271-281.
87. Kunath K, Merdan T, Hegener O, et al. Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. J Gene Med 2003; 5: 588-599.
88. Petersen H. Structurally modified polyethylenimines and their interpolyelectrolyte complexes with dna as non-viral gene delivery systems. PhD thesis, Philipps University of Marburg, Germany, 2002.
89. Akiyama Y, Harada A, Nagasaki Y, et al. Synthesis of poly(ethylene glycol)-block-poly(ethylenimine) possessing an acetal group at the PEG end. Macromolecules 2000; 33: 5841-5845.
90. Ahn C-H, Chae SY, Bae YH, et al. Biodegradable poly(ethylenimine) for plasmid DNA delivery. J Control Release 2002; 80: 273-282.
91. Shuai X, Merdan T, Unger F, et al. Novel biodegradable ternary copolymers hy-PEI-g-PCL-b-PEG: synthesis, characterization, and potential as efficient nonviral gene delivery vectors. Macromolecules 2003; 36: 5751-5759.
92. Petersen H, Merdan T, Kunath K, et al. Poly(ethylenimine-co-L-lactamide-co-succinamide): a biodegradable polyethylenimine derivative with an advantageous pH-dependent hydrolytic degradation for gene delivery. Bioconjugate Chem 2002; 13: 812-821.
93. Lee Y, Koo H, Jin GW, et al. Poly(ethylene oxide sulfide): new poly(ethylene glycol) derivatives degradable in reductive conditions. Biomacromolecules 2005; 6: 24-26.
94. Kichler A, Chillon M, Leborgne C, et al. Intranasal gene delivery with a polyethylenimine-PEG conjugate. J Control Release 2002; 81: 379-388.
95. Tang GP, Zeng JM, Gao SJ, et al. Polyethylene glycol modified polyethylenimine for improved CNS gene transfer: effects of PEGylation extent. Biomaterials 2003; 24: 2351-2362.
96. Finsinger D, Remy JS, Erbacher P, et al. Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery. Gene Ther 2000; 7: 1183-1192.
97. Ogris M, Brunner S, Schuller S, et al. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 1999; 6: 595-605.
98. Kircheis R, Schuller S, Brunner S, et al. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J Gene Med 1999; 1: 111-120.
99. Nguyen HK, Lemieux P, Vinogradov SV, et al. Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther 2000; 7: 126-138.
100. Woodle MC, Scaria P, Ganesh S, et al. Sterically stabilized polyplex: ligand-mediated activity. J Control Release 2001; 74: 309-311.
101. Blessing T, Kursa M, Holzhauser R, et al. Different strategies for formation of PEGylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjugate Chem 2001; 12: 529-537.
102. Kursa M, Walker GF, Roessler V, et al. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjugate Chem 2003; 14: 222-231.
103. Ogris M, Walker G, Blessing T, et al. Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J Control Release 2003; 91: 173-181.
104. Wolfert MA, Schacht EH, Toncheva V, et al. Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers. Hum Gene Ther 1996; 7: 2123-2133.
105. Plank C, Mechtler K, Szoka FC, et al. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene deliver. Hum Gene Ther 1996; 7: 1437-1446.
106. Dash PR, Read ML, Fisher KD, et al. Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin. J Biol Chem 2000; 275: 3793-3802.
107. Fisher KD, Ulbrich K, Subr V, et al. A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression. Gene Ther 2000; 7: 1337-1343.
108. Oupicky D, Howard KA, Konak C, et al. Steric stabilization of poly-L-lysine/DNA complexes by the covalent attachment of semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]. Bioconjugate Chem 2000; 11: 492-501.
109. Ward CM, Pechar M, Oupicky D, et al. Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged plasma circulation in vivo. J Gene Med 2002; 4: 536-547.
110. Trubetskoy VS, Wong SC, Subbotin V, et al. Recharging cationic DNA complexes with highly charged polyanions for in vitro and in vivo gene delivery. Gene Ther 2003; 10: 261-271.
111. Oupicky D, Ogris M, Howard KA, et al. Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. Mol Ther 2002; 5: 463-472.
112. Tseng WC, Jong CM. Improved stability of polycationic vector by dextran-grafted branched polyethylenimine. Biomacromolecules 2003; 4: 1277-1284.
113. Tseng WC, Tang CH, Fang TY. The role of dextran conjugation in transfection mediated by dextran-grafted polyethylenimine. J Gene Med 2004; 6: 895-905.
114. Kircheis R, Wightman L, Schreiber A, et al. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 2001; 8: 28-40.
115. Pun SH, Bellocq NC, Liu A, et al. Cyclodextrin-modified polyethylenimine polymers for gene delivery. Bioconjugate Chem 2004; 15: 831-840.
116. Brownlie A, Uchegbu IF, Schatzlein AG. PEI-based vesicle-polymer hybrid gene delivery system with improved biocompatibility. Int J Pharm 2004; 274: 41-52.
117. Han S, Mahato RI, Kim SW. Water-soluble lipopolymer for gene delivery. Bioconjugate Chem 2001; 12: 337-345.
118. Kim S, Choi JS, Jang HS, et al. Hydrophobic modification of polyethyleneimine for gene transfectants. Bull Korean Chem Soc 2001; 22: 1069-1075.
119. Kabanov AV, Lemieux P, Vinogradov S, et al. Pluronic block copolymers: novel functional molecules for gene therapy. Adv Drug Deliv Rev 2002; 54: 223-233.
120. Ochietti B, Guerin N, Vinogradov SV, et al. Altered organ accumulation of oligonucleotides using polyethyleneimine grafted with poly(ethylene oxide) or pluronic as carriers. J Drug Target 2002; 10: 113-121.
121. Ochietti B, Lemieux P, Kabanov AV, et al. Inducing neutrophil recruitment in the liver of ICAM-1-deficient mice using polyethyleneimine grafted with Pluronic P123 as an organ-specific carrier for transgenic ICAM-1. Gene Ther 2002; 9: 939-945.
122. Gebhart CL, Sriadibhatla S, Vinogradov S, et al. Design and formulation of polyplexes based on pluronic-polyethyleneimine conjugates for gene transfer. Bioconjugate Chem 2002; 13: 937-944.
123. Batrakova EV, Miller DW, Li S, et al. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. J Pharmacol Exp Ther 2001; 296: 551-557.
124. Kuo JH. Effect of Pluronic-block copolymers on the reduction of serum-mediated inhibition of gene transfer of polyethyleneimine-DNA complexes. Biotechnol Appl Biochem 2003; 37: 267-271.
125. Kakizawa Y, Harada A, Kataoka K. Environment-sensitive stabilization of core-shell structured polyion complex micelle by reversible cross-linking of the core through disulfide bond. J Am Chem Soc 1999; 121: 11 247-11 248.
126. Miyata K, Kakizawa Y, Nishiyama N, et al. Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. J Am Chem Soc 2004; 126: 2355-2361.
127. Blessing T, Remy JS, Behr JP. Monomolecular collapse of plasmid DNA into stable virus-like particles. Proc Natl Acad Sci U S A 1998; 95: 1427-1431.
128. McKenzie DL, Smiley E, Kwok KY, et al. Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers. Bioconjugate Chem 2000; 11: 901-909.
129. Park Y, Kwok KY, Boukarim C, et al. Synthesis of sulfhydryl cross-linking poly(ethylene glycol)-peptides and glycopeptides as carriers for gene delivery. Bioconjugate Chem 2002; 13: 232-239.
130. Saito G, Swanson JA, Lee K-D. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug Deliv Rev 2003; 55: 199-215.
131. Collins DS, Unanue ER, Harding CV. Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J Immunol 1991; 147: 4054-4059.
132. Kakizawa Y, Harada A, Kataoka K. Glutathione-sensitive stabilization of block copolymer micelles composed of antisense DNA and thiolated poly(ethylene glycol)-block-poly(L-lysine): a potential carrier for systemic delivery of antisense DNA. Biomacromolecules 2001; 2: 491-497.
133. Gosselin MA, Guo W, Lee RJ. Incorporation of reversibly cross-linked polyplexes into LPDII vectors for gene delivery. Bioconjugate Chem 2002; 13: 1044-1053.
134. Carlisle RC, Etrych T, Briggs SS, et al. Polymer-coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction. J Gene Med 2004; 6: 337-344.
135. Oupicky D, Carlisle RC, Seymour LW. Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo. Gene Ther 2001; 8: 713-724.
136. Aoki K, Furuhata S, Hatanaka K, et al. Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity. Gene Ther 2001; 8: 508-514.
137. Kunath K, von Harpe A, Fischer D, et al. Galactose-PEI-DNA complexes for targeted gene delivery: degree of substitution affects complex size and transfection efficiency. J Control Release 2003; 88: 159-172.
138. Zanta MA, Boussif O, Adib A, et al. In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. Bioconjugate Chem 1997; 8: 839-844.
139. Sato A, Kawakami S, Yamada M, et al. Enhanced gene transfection in macrophages using mannosylated cationic liposome-polyethylenimine-plasmid DNA complexes. J Drug Target 2001; 9: 201-207.
140. Diebold SS, Kursa M, Wagner E, et al. Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells. J Biol Chem 1999; 274: 19 087-19 094.
141. Lu Y, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 2002; 54: 675-693.
142. Chiu SJ, Ueno NT, Lee RJ. Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, herceptin) conjugated polyethylenimine. J Control Release 2004; 97: 357-369.
143. Buschle M, Cotten M, Kirlappos H, et al. Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex. Hum Gene Ther 1995; 6: 753-761.
144. O'Neill MM, Kennedy CA, Barton RW, et al. Receptor-mediated gene delivery to human peripheral blood mononuclear cells using anti-CD3 antibody coupled to polyethylenimine. Gene Ther 2001; 8: 362-368.
145. Vinogradov S, Batrakova E, Li S, et al. Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells. Bioconjugate Chem 1999; 10: 851-860.
146. Ziegler A, Seelig J. Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters. Biophys J 2004; 86: 254-263.
147. Suzuki T, Futaki S, Niwa M, et al. Possible existence of common internalization mechanisms among arginine-rich peptides. J Biol Chem 2002; 277: 2437-2443.
148. Leifert JA, Harkins S, Whitton JL. Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity. Gene Ther 2002; 9: 1422-1428.
149. Kaplan I, Wadia J, Dowdy S. Cationic TAT peptide transduction domain enters cells by macropinocytosis. J Control Release 2005; 102: 247-253.
150. Rudolph C, Plank C, Lausier J, et al. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J Biol Chem 2003; 278: 11 411-11 418.
151. Ho A, Schwarze SR, Mermelstein SJ, et al. Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res 2001; 61: 474-477.
152. Escriou V, Carriere M, Scherman D, et al. NLS bioconjugates for targeting therapeutic genes to the nucleus. Adv Drug Deliv Rev 2003; 55: 295-306.
153. Zanta MA, Belguise-Valladier P, Behr JP. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci U S A 1999; 96: 91-96.
154. Ohana P, Gofrit O, Ayesh S, et al. Regulatory sequences of the H19 gene in DNA based therapy of bladder cancer. Gene Ther Mol Biol 2004; 8: 181-192.
155. Schaffer DV, Fidelman NA, Dan N, et al. Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol Bioeng 2000; 67: 598-606.
156. Jones GD, Langsjoen A, Neumann MMC, et al. The polymerization of ethyleneimine. J Org Chem 1944; 9: 125-147.
157. von Harpe A. Polyethylenimine derivatives for gene transfer: polymer synthesis, coupling of ligands and interactions with DNA, PhD thesis, Philipps University of Marburg, Germany, 2000.
158. Foglieni C, Bragonzi A, Cortese M, et al. Glomerular filtration is required for transfection of proximal tubular cells in the rat kidney following injection of DNA complexes into the renal artery. Gene Ther 2000; 7: 279-285.
159. Benns JM, Mahato RI, Kim SW. Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine. J Control Release 2002; 79: 255-269.
160. Erbacher P, Remy JS, Behr JP. Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther 1999; 6: 138-145.
161. Kircheis R, Wightman L, Kursa M, et al. Tumor-targeted gene delivery: an attractive strategy to use highly active effector molecules in cancer treatment. Gene Ther 2002; 9: 731-735.
162. Hildebrandt IJ, Iyer M, Wagner E, et al. Optical imaging of transferrin targeted PEI/DNA complexes in living subjects. Gene Ther 2003; 10: 758-764.
163. Lee H, Kim TH, Park TG. A receptor-mediated gene delivery system using streptavidin and biotin-derivatized, pegylated epidermal growth factor. J Control Release 2002; 83: 109-119.
164. Li S, Tan Y, Viroonchatapan E, et al. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am J Physiol Lung Cell Mol Physiol 2000; 278: L504-511.